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 THE DEEP INFERIOR EPIGASTRIC ARTERY PERFORATOR FLAP
FOR AUTOLOGOUS RECONSTRUCTION OF LARGE PARTIAL
MASTECTOMY DEFECTS
MORTEZA ENAJAT, M.D., B.A.,1 WARREN M. ROZEN, M.B.B.S., B.Med.Sc., P.G.Dip.Surg.Anat., Ph.D.,2*
IAIN S. WHITAKER, B.A. (Hons), M.A. Cantab., M.B.B.Chir., M.R.C.S., Ph.D.,1,2 JEROEN M. SMIT, M.D.,1
RENE R. W. J. VAN DER HULST, M.D., Ph.D.,1 and RAFAEL ACOSTA, M.D., E.B.O.P.R.A.S.1
Background: Breast conservation surgery in the treatment of early stage breast cancer has become increasingly utilized as a means to
avoiding mastectomy. While partial mastectomy defects (PMDs) may often be cosmetically acceptable, some cases warrant consideration
of reconstructive options, and while several reconstructive options have been described in this role, a series of deep inferior epigastric per-
forator (DIEP) ﬂaps has not been reported to date. Methods: A cohort of 18 patients undergoing PMD reconstruction with a DIEP ﬂap
were included. Patient-speciﬁc data, operation details, cosmetic results, and complication rates were assessed. Oncologic outcomes, in
particular recurrence rates, were also evaluated. Results: In our series there were no cases of partial or total ﬂap necrosis, and overall
complications were low. There were two cases of wound infection (both had undergone radiotherapy), managed conservatively, and one
case of reoperation due to hematoma. There were no cancer recurrences or effect on oncologic management. Cosmetic outcome was
rated as high by both patients and surgeon. The results were thus comparable with other reconstructive options. Conclusion: Although au-
tologous reconstruction has an established complication rate, our results suggest that the DIEP ﬂap may be of considerable value for
delayed reconstruction of selected larger partial mastectomy defects. VC 2010 Wiley-Liss, Inc. Microsurgery 31:12–17, 2011.
Breast conservation surgery (BCS) is widely the treat-
ment of choice for early stage breast cancer, with BCS
shown to signiﬁcantly reduce breast deformity and mini-
mize the invasiveness of breast cancer treatment, without
compromising oncologic outcomes.1–3 Although BCS can
preserve an adequate amount of breast tissue to avoid the
use of reconstructive techniques, unacceptable disﬁgure-
ment remains a problem in up to 30% of patients, many
of whom will opt for reconstruction of their partial mas-
tectomy defect (PMD).4,5 In such cases, a variety of
reconstructive options have been described, ranging from
immediate reconstruction with local tissue advancement
or rotation, or with prosthetic implants.6 The use of dis-
tant autologous options have included latissimus dorsi
ﬂaps,7 transverse rectus abdominis myocutaneous
(TRAM) ﬂaps,8 and the superﬁcial inferior epigastric ar-
tery (SIEA) ﬂap,9 all of which have been effective in this
setting.
The deep inferior epigastric artery (DIEA) perforator
(DIEP) ﬂap has been popularized for postmastectomy
reconstruction, and offers a range of advantages over the
other reconstructive options described.10,11 It has been
shown to have a consistent blood supply, versatility in
volume and shape, and a donor site proﬁle considerably
superior to other myocutaneous ﬂap options.10,11 While
free ﬂaps based on the DIEA have been described in
postmastectomy breast reconstruction and in augmenta-
tion mammoplasty, reports of their use in the reconstruc-
tion of PMDs are limited to case reports only.12,13 The
current study is the ﬁrst to consider the DIEP ﬂap in this
role in a consecutive series of patients, providing a
detailed assessment of outcomes and comparing this
approach with other established reconstructive options.
METHODS
The study comprised a cohort of 18 consecutive
patients with PMDs after BCS for breast carcinoma. All
patients were recruited through a single reconstructive
surgeon at a single institution, with all referrals through a
single oncologic surgeon at the same institution. BCS
was planned based on a tumor size of 3 cm or less, lack
of palpable axillary lymph nodes, and the absence of dis-
tant metastases. Adjuvant radiotherapy, chemotherapy,
and endocrine therapies and all oncologic follow-up were
dictated by the oncologic surgeon, and the decision for
reconstruction was made between patient and oncologic
surgeon. All patients were delayed reconstructions, with a
minimum of 6 months following oncologic surgery before
any of the referrals were made. While over 20% of
patients in this series did not have adjuvant radiotherapy
(see Table 1), delayed reconstruction was selected in all
cases as a means to avoiding any delay in the administra-
tion of adjuvant therapy and to minimize the effects of
radiotherapy (on both the skin paddle and subcutaneous
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tissues of the ﬂap). However, in cases where it is known
that radiotherapy is not going to be used, immediate
reconstruction may certainly be considered. The recon-
structive options were discussed in each case, with deci-
sion for DIEP ﬂap partial breast reconstruction made
between patient and reconstructive surgeon.
Demographic data was collected in each case, includ-
ing age, associated risk factors, and oncologic data which
included tumor speciﬁcs, the use of adjuvant therapies,
and axillary staging (see Table 1). Operative outcomes
and complications were assessed, with patients followed
up every 6 months following reconstruction, and a mini-
mum of 3 years follow-up in each case. Cosmetic out-
come was evaluated qualitatively by both the surgeon
and patients, with patients asked for their subjective opin-
ion (poor, average, good) and surgeons asked to assess
outcome based on shape, symmetry, and overall appear-
ance (poor, average, good).
Surgical Technique
Surgical approach to DIEP ﬂap harvest was performed
in a routine manner, as per full mastectomy reconstruc-
tion, with a full lower abdominal ellipse marked preoper-
atively, and DIEA perforators marked on the abdomen
based on localization with imaging. This preoperative
ﬂap planning was achieved with the use of computed to-
mographic angiography (CTA) imaging in all cases, aid-
ing perforator selection and the planning of ﬂap harvest
(see Table 2).
In all cases a two-surgeon team was used, with one
team undertaking ﬂap harvest and the other preparing re-
cipient vessels. The DIEA and deep inferior epigastric
vein (DIEV) comprised the donor vessels in all cases,
and the recipient vessels were the internal mammary ar-
tery (IMA) and veins (IMVs) or the circumﬂex scapula
artery and veins, and the cephalic vein used as a source of
secondary venous drainage (see Table 2). In all cases, the
defect was extended to the chest wall, with selective under-
mining of the remaining breast tissue at the level of the
pectoral fascia, and exposure of internal mammary perfora-
tors and the circumﬂex scapula vessels. Selection of the
vascular pedicle was then made based on the ability for rel-
ative exposure of the vascular pedicle, proximity of the
defect to the exposed pedicles, and the effect of radiother-
apy changes on the exposed vascular pedicles. As such,
there was no correlation between the location of the defect
and the chosen recipient pedicle. Arterial anastomoses
were sutured in all cases, while venous anastomoses were
performed with a microvascular anastomotic coupling de-
vice (Microvascular Anastomotic Coupling System, Syno-
vis Micro Companies Alliance, St Paul, MN).
After venous anastomosis has been completed, an
implantable Doppler probe is placed around the veins to
monitor anastomotic patency during insetting and in the
postoperative period (Cook-Swartz implantable Doppler
probe; Cook Medical1, Cook Ireland, Limerick, Ireland).
Postoperative monitoring was achieved with a combina-
tion of the implantable Doppler probe and clinical assess-
ment, and all cases were monitored for 7 postoperative
days.
Statistical Analysis
Data is presented as population means, with standard
deviations and/or 95% conﬁdence intervals of differences
given. Statistical analysis was performed using statistical
package for the social sciences (SPSS) for Windows (ver-
sion 16.0, SPSS Incorporated, Chicago, IL).
Table 1. Patient Demographic and Oncologic Details
Demographic data
Mean age (years) 53.5 (SD 5 8.2);
range: 34–66
Oncologic details
Tumor size (maximal dimension) (mm) mean 23 (SD 5 8)
Tumor histology
Ductal carcinoma in situ (%) 22%
Invasive ductal carcinoma (%) 56%
Invasive lobular carcinoma (%) 22%
Adjuvant radiotherapy 14/18 (78%)
Adjuvant chemotherapy 5/18 (28%)
Adjuvant endocrine therapy 9/18 (50%)
Axillary staging
None 2/18 (11%)
Sentinel lymph node biopsy 1/18 (6%)
Axillary clearance 15/18 (83%)
SD 5 standard deviation.
Table 2. Operative Details
Operative details
Timing 0 immediate/18 delayed
Sides 18 unilateral/0 bilateral
Defect
Upper medial quadrant 1/18 (6%)
Upper lateral quadrant 10/18 (56%)
Lower medial quadrant 2/18 (11%)






Imaging ﬁndings 18/18 cases suitable deep
inferior epigatric artery
(DIEA) perforators >1 mm
Imaging concordance 100% concordance Doppler
ultrasound and CTA
Primary donor vessels Deep inferior epigastric
artery/vein (all cases)
Primary recipient vessels Internal mammary artery/vein
or circumﬂex scapula artery/vein
Secondary donor vein Superﬁcial inferior epigastric
veins (all cases)
Secondary recipient vein Cephalic vein (all cases)
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RESULTS
Eighteen patients underwent delayed, unilateral DIEP
ﬂap breast reconstruction of a PMD. Mean patient age
was 53.5 years (range 34–66), patients had a range of
body habitus (no patients were morbidly obese), and
mean time interval between initial BCS and reconstruc-
tion was 2.4 years. Patients had relatively large tumors
(mean size 23 mm) and a range of tumor histology. Ad-
juvant therapies were used in the majority of cases (see
Table 1), with 14 of the 18 patients having undergone ad-
juvant radiotherapy (mean dosage of 50 Gy).
All defects were considered deforming by the patient,
and were all large defects in small to medium sized
breasts. The majority of defects were in the lateral half
of the breast (15/18 5 83% of cases).
There was only one major complication in the series,
comprising a hematoma requiring return to theater (see
Table 3). Otherwise, there were no cases of partial or
total ﬂap necrosis, no anastomotic revisions, and overall
complications were low. There were two cases of wound
infection (both had undergone radiotherapy), managed
conservatively. There was no donor site morbidity on ei-
ther subjective questioning or examination at any follow-
up appointments. There were no cancer recurrences or
effect on oncologic management. Cosmetic outcome was
rated as high by both patients and surgeon in all cases
(see Figs. 1A and 1B).
DISCUSSION
BCS has become increasingly utilized in the manage-
ment of breast cancer, and while cosmetic outcomes may
be achieved in many cases, BCS can include a broad
Table 3. Operative Outcomes
Operative complications (n/%)
Complete ﬂap loss 0 (0%)
Partial ﬂap loss 0 (0%)
Arterial trombosis 0 (0%)
Venous thrombosis 0 (0%)
Venous congestion 1/18 (6%)
Hematoma 1/18 (6%)
Superﬁcial wound infection 2/18 (11%)




Abdominal weakness (subjective or objective) 0 (0%)
Abdominal bulge 0 (0%)
Abdominal herniation 0 (0%)
Oncologic outcomes (n/%)
Delays in administering adjuvant therapies 0 (0%)
Tumor recurrence 0 (0%)
Cosmetic outcomes
Patient-rated score (mean) high
Surgeon-rated score (mean) high
Figure 1. A: Preoperative photograph of a patient with a right partial mastectomy defect (PMD). B: Postoperative photograph after deep in-
ferior epigastric artery perforator (DIEP) ﬂap reconstruction of the partial mastectomy defect (PMD). [Color ﬁgure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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spectrum of resection volumes, and thus preservation of
an adequate amount of breast tissue for esthetically pleas-
ing outcomes may not be uniform. Speciﬁc predictors of
an unsatisfactory result after BCS included large tumor
size relative to the size of the breast and the use of radio-
therapy. Reconstructive options have thus been sought,
including single-stage implant-based reconstruction, with
or without the use of tissue expansion, autologous recon-
struction using local tissue or free ﬂaps, and reconstruc-
tion using a combination of autologous tissue and pros-
thetic implants.
Reconstruction with the use of prosthetic implants has
been proposed as technically easier and less invasive
compared to autologous reconstruction, and with quicker
convalescence may require shorter hospitalization
times.14–16 However, there are notable disadvantages with
the use of implants when compared to autologous recon-
struction. Where tissue expansion is needed, the use of
expansion can be associated with pain for the patient,
and where irradiation has been performed (a majority of
BCS cases) tissue expansion can be problematic and
associated with increased pain and inadequate expansion.
Implant-related complications are also of concern, with
the risk of infection, capsular contracture, and implant
extrusion markedly increased in the presence of irradiated
tissue.14,15
Given these problems, autologous tissue reconstruc-
tion has been described as a preferred option.15,17 While
the effects of radiotherapy are certainly more marked for
implant-based reconstruction, the effects on autologous
tissues are certainly a concern, and our preference is to
delay reconstruction in all cases. These effects can occur
on both fat and skin, with the effects on subcutaneous fat
most feared, with fat necrosis not uncommon after irradi-
ation.18 A recent review by Losken and Hamdi provided
a comprehensive overview of reconstructive options after
PMDs.19 While reconstructive options with local tissue or
ﬂaps were clearly outlined and described as preferred
options, the use of distant ﬂaps in this setting were not
extensively explored. Given the increasingly low compli-
cations rates described in the literature and in our experi-
ence, free tissue transfer is fast becoming a safe and
potentially improved reconstructive option in this setting.
In fact, Kronowitz et al. found free tissue transfer to
PMDs to have signiﬁcantly less complications compared
to local tissue options.6 One particular beneﬁt of free tis-
sue transfer is the ability to inset the ﬂap into defects in
all four quadrants of the breast with relative ease. Local
tissue ﬂaps require somewhat more planning in this
regard. The thoracodorsal artery perforator ﬂap is of par-
ticular beneﬁt for lateral and central defects, similar to
that of the latissimus dorsi myocutaneous ﬂap.6,17,20
Medial defects are more difﬁcult to reconstruct with local
options, and may be particularly suited to free ﬂap recon-
struction. In addition, many patients do not have sufﬁ-
cient volume within local tissue for such an option.
Autologous options described in the setting of BCS
include the use of local tissue,6 free latissimus dorsi myo-
cutaneous ﬂaps,7 muscle-sparing TRAM ﬂaps,8 SIEA
ﬂaps,9 and thoracodorsal artery perforator (TDAP) ﬂaps.17
While we prefer the DIEP ﬂap, with its known beneﬁts
in terms of versatility in shape and volume and its good
donor site proﬁle, other authors have offered other
options, each with their own morbidity proﬁles. The latis-
simus dorsi ﬂap has been described with rates of partial
ﬂap loss of 6%, total ﬂap loss of 2%, and an overall
complication rate of 33%,21 and being a denervated mus-
culocutaneous ﬂap, volume changes with muscle atrophy
can be problematic. Similarly, the pedicled and free mus-
cle-sparing TRAM ﬂaps described in this setting are asso-
ciated with worse donor site outcomes than the DIEP
ﬂap.8,10,11,22,23 The DIEP ﬂap has a long pedicle for ease
of reconstruction of all breast defects, is widely outside
of the irradiated ﬁeld, and has been associated with good
donor- and ﬂap-related outcomes in many reported series.
The current series highlights that the complication rates
of DIEP ﬂaps in the repair of PMDs are similar to that in
postmastectomy reconstruction, and to delayed recon-
struction after BCS using other reconstructive options.
The good cosmetic results universally reported add to
these beneﬁts. The additional esthetic beneﬁt of the
abdominoplasty was noted by many patients.
In the current series, a DIEP ﬂap was used in all
cases, with this decision made based on surgeon and
patient preference after performing a preoperative CTA
for vascular mapping. The CTA is used to deﬁne the
dominant vascular supply to the lower abdominal wall,
with all perforators over 1 mm identiﬁed, and the super-
ﬁcial inferior epigastric artery (SIEA) also identiﬁed.
While we do consider the use of an SIEA ﬂap, the
SIEA itself is frequently absent altogether or too small
for use in free tissue transfer, and thus the DIEP ﬂap is
preferred, as occurred in all cases of the current series.24
In cases where a SIEA ﬂap may be considered, the
same lower abdominal elipse would be designed, with
ﬂap design based on the course of the SIEA as demon-
strated on CTA. An additional technical consideration is
the use of a skin paddle as part of the ﬂap. In all cases
within this series, there was a skin defect included as
part of the partial mastectomy specimen, and/or radiation
changes that warranted excision. The skin paddle of the
DIEP ﬂap was thus useful for reconstruction of such a
deﬁcit, and also able to be used as a monitoring paddle
for postoperative monitoring of the ﬂap clinically. A de-
epithelialized ﬂap may be used where skin is not
required, with the ﬂap inset as a buried ﬂap, and able to
be monitored postoperatively with an implantable Dopp-
ler probe.25,26
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While the argument exists for preservation of the ab-
dominal donor site for the case of future need for post-
mastectomy reconstruction, recurrence rates in patients
having undergone BCS after breast cancer are low over-
all, with only 5–8% requiring salvage mastectomy.14,16 In
these few cases, other satisfactory reconstructive options
(both prosthetic and autologous) still remain and thus
preservation of this tissue in up to 95% of cases where it
can be effectively used may not be warranted. Case
selection is thus highly important in employing this
reconstructive option, with clear margins, lack of regional
spread, and time to reconstruction all important selection
considerations. With no detriment to oncologic outcomes
identiﬁed in the current series, it is pertinent that postre-
construction oncologic follow-up is essential, with timely
administration of adjuvant therapies, ongoing clinical ex-
amination and mammography, and consideration of
advanced imaging technologies all important. Magnetic
resonance imaging (MRI) in particular has been shown to
be useful in this setting.27,28 The majority of local recur-
rences after BCS are known to occur within the ﬁrst 2
years of presentation,1 and while recurrence rates of 5–
8% over a 5-year period are described,1,2 delayed recon-
struction minimizes the need for revision surgery. The
longer the interval between BCS and reconstruction, the
more likely it is that recurrence is detected prior to
reconstruction, and we prefer delayed reconstruction for
this reason.
CONCLUSION
BCS has become a valuable option in the treatment
of breast cancer, but does not rule out the need for breast
reconstruction. There are many variables that can inﬂu-
ence the choice of reconstruction in this setting, and thus
many options have been described. We have described
our experience with the use of the DIEP ﬂap in delayed
breast reconstruction after BCS. We have found the DIEP
ﬂap to be a safe, effective, and esthetic tool for recon-
struction of larger partial mastectomy defects, particularly
in small to medium sized breasts. The technique thus
offers a useful alternative to other reconstructive options
in this setting.
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